OPRX (OptimizeRx Corporation) Stock Financials & Earnings

OPRXOptimizeRx Corporation

Mkt Cap$128M

Revenue (TTM)$109M

Net Income (TTM)$5M

EPS (TTM)$0.26

Free Cash Flow (TTM)$19M

Gross Margin67.3%

Op. Margin11.0%

Net Margin4.7%

FCF Margin17.0%

P/S Ratio (TTM)1.2x

P/E Ratio (TTM)25.0x

YoY Rev Growth+18.8%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$13M	$7M	-$7M
Q2 23	$14M	$8M	-$5M
Q3 23	$16M	$10M	-$4M
Q4 23	$28M	$18M	-$11M
Q1 24	$20M	$12M	-$5M
Q2 24	$19M	$12M	-$4M
Q3 24	$21M	$13M	-$9M
Q4 24	$32M	$22M	$4M
Q1 25	$22M	$13M	-$2M
Q2 25	$29M	$19M	$3M
Q3 25	$26M	$18M	$2M
Q4 25	$32M	$24M	$9M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 23	—	$14M	—
Q2 23	—	$12M	—
Q3 23	$48K	$13M	$30K
Q4 23	—	$19M	—
Q1 24	$71K	$16M	—
Q2 24	$71K	$14M	—
Q3 24	$91K	$13M	—
Q4 24	—	$17M	—
Q1 25	$91K	$14M	—
Q2 25	—	$14M	—
Q3 25	$80K	$14M	$60K
Q4 25	—	$12M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$16M	$57M	$74M
Q2 23	$10M	$53M	$63M
Q3 23	$10M	$54M	$64M
Q4 23	$14M	$0	$14M
Q1 24	$15M	$0	$15M
Q2 24	$15M	$0	$15M
Q3 24	$16M	$0	$16M
Q4 24	$13M	$0	$13M
Q1 25	$17M	$0	$17M
Q2 25	$17M	$0	$17M
Q3 25	$20M	$0	$20M
Q4 25	$23M	$0	$23M

Shares Outstanding

Revenue Per Employee

Revenue / Employee